TipRanks (Tue, 15-Sep 7:15 AM ET)
Notable healthcare headlines for the week: UnitedHealth, Amgen, and CooperCompanies in focus
Seeking Alpha News (Sun, 13-Sep 9:05 AM ET)
Top West Pharmaceutical Executive Makes Major Move With Insider Stock Sale
TipRanks (Thu, 10-Sep 10:04 PM ET)
West to Participate in Upcoming Investor Conferences
PRNewswire (Wed, 26-Aug 4:00 PM ET)
West Declares Quarterly Dividend
PRNewswire (Tue, 21-Jul 4:00 PM ET)
West to Host Second-Quarter 2026 Conference Call
PRNewswire (Tue, 7-Jul 6:00 AM ET)
PRNewswire (Wed, 1-Jul 4:30 PM ET)
West Pharmaceutical Services Raises Full-Year Guidance as High-Value Products Drive 21% Sales Growth
Market Chameleon (Thu, 23-Apr 7:45 AM ET)
West Pharmaceutical Raises 2026 Outlook as High-Value Products Drive Double-Digit Growth
Market Chameleon (Thu, 23-Apr 4:00 AM ET)
WST Raises Guidance After Strong Third Quarter—HVP Components Fuel Double-Digit Growth
Market Chameleon (Thu, 23-Oct 7:56 AM ET)
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
West Pharmaceutical Servs trades on the NYSE stock market under the symbol WST.
As of September 15, 2026, WST stock price climbed to $360.35 with 59,850 million shares trading.
WST has a beta of 0.85, meaning it tends to be less sensitive to market movements. WST has a correlation of 0.10 to the broad based SPY ETF.
WST has a market cap of $25.37 billion. This is considered a Large Cap stock.
Last quarter West Pharmaceutical Servs reported $872 million in Revenue and $2.37 earnings per share. This beat revenue expectation by $34 million and exceeded earnings estimates by $.29.
In the last 3 years, WST traded as high as $413.70 and as low as $187.43.
The top ETF exchange traded funds that WST belongs to (by Net Assets): VTI, VOO, VO, VUG, IVV.
WST has outperformed the market in the last year with a price return of +42.5% while the SPY ETF gained +16.7%. WST has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +9.7% and +5.6%, respectively, while the SPY returned +2.7% and -1.0%, respectively.
WST support price is $349.49 and resistance is $360.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that WST shares will trade within this expected range on the day.